ADM Korea Targets Prostate Cancer For Niclosamide-Based Drug Trial
11 Jul 2024 //
PR NEWSWIRE
Korean firm Hyundai Bioscience soon to initiate global clinical development
22 Apr 2024 //
BIOSPECTRUM ASIA
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide
28 Mar 2022 //
GLOBENEWSWIRE
TFF Reports Inhaled Niclosamide Inhibits Viral Replication of Omicron Variant
24 Feb 2022 //
GLOBENEWSWIRE
TFF Pharma Completes Enrollment in Phase 1 Evaluating Niclosamide for COVID-19
27 Jan 2022 //
GLOBENEWSWIRE
UNION therapeutics announces enrollment of first patient in the PREVENT study
22 Oct 2021 //
CISION
First Wave BioPharma Forms Steering Committee for Phase 2a PASSPORT
21 Oct 2021 //
GLOBENEWSWIRE
First Wave BioPharma Announces Dosing of First Patient in Ph2b Clinical Trial
14 Oct 2021 //
GLOBENEWSWIRE
NeuroBo: +ve Recommendation from Independent Data Safety Monitoring Committee
13 Oct 2021 //
BIOSPACE
First Wave BioPharma Begins Patient Screening for Phase 2b Niclosamide
28 Sep 2021 //
GLOBENEWSWIRE
AzurRx: +ve data from Part 1 PII Trial of Niclosamide for COVID-19 GI infections
09 Sep 2021 //
GLOBENEWSWIRE
AzurRx BioPharma Submits an Investigational New Drug Application for Niclosamide
08 Sep 2021 //
BIOSPACE
Phase II clinical trial of Niclosamide drug for COVID-19 patients begins
06 Jun 2021 //
THE ECONOMIC TIMES
Hyundai Bioscience leads in the repurposing of Niclosamide
08 Apr 2021 //
PRNASIA
Hyundai Bioscience leads in the repurposing of Niclosamide
07 Apr 2021 //
PRNASIA
UNION therapeutics’ Covid-19 candidates meet endpoints in trial
07 Apr 2021 //
CLINICALTRIALSARENA
AzurRx Announces Exclusive Worldwide License Agreement
04 Jan 2021 //
GLOBENEWSWIRE
Daewoong et Tufts Medical Center joignent leurs forces pour la phase 2
30 Oct 2020 //
PRNEWSWIRE
Daewoong Partners with Tufts Medical Center for Ph2 Trial Niclosamide
29 Oct 2020 //
PRNASIA
Danish biotech UNION adds program to prevent COVID-19 niclosamide
21 Oct 2020 //
PRNEWSWIRE
Daewoong begins phase 1 trial of niclosamide as COVID-19 drug in Korea
10 Oct 2020 //
KOREAHERALD
UNION therapeutics A/S completes dosing of healthy volunteers with UNI911
24 Aug 2020 //
PRNEWSWIRE
TFF Pharmaceuticals Signs Worldwide Licensing Agreement with Union Therapeutics
17 Aug 2020 //
CONTRACTPHARMA
UNION enters option agreement to acquire worldwide exclusive license
13 Aug 2020 //
PRNEWSWIRE
Mankind , Daewoong to initiate ph1 trial on new formulation of niclosamide
11 Aug 2020 //
PHARMABIZ
ANA & Quotient Sciences Announce Partnership to Manufacture Niclosamide
10 Aug 2020 //
PRESS RELEASE
ANA Therapeutics Announces USFDA Clearance Of IND App To Trial Of Niclosamide
04 Aug 2020 //
PRNEWSWIRE
UNION Receives Approval From Danish Medicines Agency to Initiate Clinical Study
01 Jul 2020 //
PRNEWSWIRE
Daewoong finds niclosamide effective against Covid-19 in animal tests
09 Jun 2020 //
PHARMACEUTICAL-TECHNOLOGY
Niclosamide removes coronavirus in ferret in 3 days: Daewoong
05 Jun 2020 //
KOREAHERALD
TFF Pharma’ Inventor Dr. Robert O. Williams III Session Repurposing Niclosamide
30 Apr 2020 //
BUSINESSWIRE
UNION therapeutics Launches COVID-19 Program in Collaboration
14 Apr 2020 //
NEWSWIRE
Merus Buys Four Products from Sanofi (SNY) for €22.5 Million
23 Feb 2016 //
BIOSPACE